$
1. 43
0
0%
$
6.63M Market Cap
- P/E Ratio
- Div Yield
16,433 Volume
-0.89 Eps
$ 1.43
Previous Close Analysts:
Want to track INAB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
IN8bio Inc. (INAB) Statistics
Valuation metrics
Market Cap 6.63M
Enterprise value -12.96M
Trailing P/E (ttm) -0.33
Forward P/E -1
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 0.27
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.76
Overview
Shares outstanding 9.77M
Float 7.03M
Shares short 296.11K
% Held by insiders 0.21%
% Held by institutions 0.33%
Average volume (10 days) 43.58K
Average volume (90 days) 68.66K
Price summary
52-Week low 1.17
52-Week high 2.73
Beta 0.04
50-Day moving average 1.57
200-Day moving average 1.76
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:30
Last split Date 6 Jun 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.72%
Return on equity -0.96%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -18.09M
Net income to common (ttm) -19.44M
Diluted EPS (ttm) -4.34
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 27.09M
Total cash per share (mrq) 5.02
Total debt (mrq) 2.78M
Total Debt/Equity (mrq) 0.1
Current ratio (mrq) 10.5%
Book value per share (mrq) 5.21
Cash Flow
Cash flow statement -12.71M
Levered free cash flow (LFCF) -5.55M
